HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUTCHMED

26.900

+0.8503.26%

Volume:9.20M

Turnover:244.44M

Market Cap:23.46B

PE:77.69

High:27.100

Open:26.250

Low:25.800

Close:26.050

Loading ...

Overview Company News Filings

BOCOM International: Innovative Drug Sector's Recovery Prospects Remain Attractive; Focus on Commercial Insurance Drug Catalog Launch

HUTCHMED (China) Ltd. Schedules Board Meeting to Approve and Announce 2025 Interim Results

HUTCHMED to Announce 2025 Half-Year Financial Results

THOMSON REUTERS

HUTCHMED to Announce 2025 Half-Year Financial Results

Hutchmed New Drug Application for Lung Cancer Combination Treatment Approved in China

MT Newswires Live

HUTCHMED (China) Ltd - Announces China Approval for Orpathys and Tagrisso Combination

THOMSON REUTERS

HUTCHMED China Ltd - China Approval Based on Phase Iii Sachi Trial

THOMSON REUTERS

BUZZ-HUTCHMED hits 2-month high on drug application for kidney cancer treatment

HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment

BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With Sintilimab

HUTCHMED (China) Ltd - Nda Acceptance in China for Fruquintinib Combination With Sintilimab

THOMSON REUTERS

HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%

Tiger Newspress

Hutchmed Completes Patient Enrollment in Phase II Gastric Cancer Trial in China

MT Newswires Live

- HUTCHMED China Ltd - HUTCHMED Completes Enrollment of Phase Ii Study

THOMSON REUTERS

Market Chatter: Hutchmed Looking Into Supply Chain Options for Blood Cancer Drug Amid US Tariffs

MT Newswires Live

Hutchmed's Tazemetostat Gets Conditional Approval in China for Follicular Lymphoma Treatment

MT Newswires Live

BRIEF-Hutchmed (China) Gets NMPA Conditional Approval For Tazverik® (Tazemetostat)

Hutchmed Receives Conditional Approval for Tazverik as Follicular Lymphoma Treatment in China

MT Newswires Live

HUTCHMED (China) Ltd - Nmpa Conditional Approval for Tazverik® (Tazemetostat) for Treatment of Relapsed or Refractory Follicular Lymphoma

THOMSON REUTERS

HUTCHMED Announces Nmpa Conditional Approval for Tazverik® (Tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/00013/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00013","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00013\",,,,,undefined,":{"symbol":"00013","market":"HK","secType":"STK","nameCN":"HUTCHMED","latestPrice":26.9,"timestamp":1752653287009,"preClose":26.05,"halted":0,"volume":9198138,"delay":0,"floatShares":872000000,"shares":872000000,"eps":0.3462516681058168,"marketStatus":"Closed","change":0.85,"latestTime":"07-16 16:08:07","open":26.25,"high":27.1,"low":25.8,"amount":244435905,"amplitude":0.049904,"askPrice":26.9,"askSize":18000,"bidPrice":26.8,"bidSize":30500,"shortable":3,"etf":0,"ttmEps":0.31398853913179997,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":5,"adr":0,"listingDate":1624982400000,"exchange":"SEHK","adjPreClose":26.05,"openAndCloseTimeList":[[1752629400000,1752638400000],[1752642000000,1752652800000]],"volumeRatio":1.592886,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00013\",,,,,undefined,":{"symbol":"00013","floatShares":872000000,"roa":"-2.14%","roe":"5.04%","lyrEps":0.346252,"volumeRatio":1.592886,"shares":872000000,"dividePrice":0,"high":27.1,"amplitude":0.049904,"preClose":26.05,"low":25.8,"week52Low":18.36,"pbRate":"3.93","psRate":"4.74","week52High":34.8,"institutionHeld":0,"latestPrice":26.9,"committee":0.257732,"eps":0.3462516681058168,"divideRate":0,"volume":9198138,"delay":0,"ttmEps":0.31398853913179997,"open":26.25,"prevYearClose":22.55,"prevWeekClose":25.55,"prevMonthClose":23.55,"prevQuarterClose":23.55,"fiveDayClose":25.65,"twentyDayClose":24.95,"sixtyDayClose":21.8,"earningDate":1754496000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00013\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1162191939","title":"BOCOM International: Innovative Drug Sector's Recovery Prospects Remain Attractive; Focus on Commercial Insurance Drug Catalog Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1162191939","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162191939?lang=en_us&edition=fundamental","pubTime":"2025-07-16 13:59","pubTimestamp":1752645593,"startTime":"0","endTime":"0","summary":"BOCOM International's latest analysis maintains a bullish stance on Hong Kong's innovative drug sector, citing valuation re-rating as the primary market driver. Current valuations retain significant...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LU2488822045.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","BK1161","LU0348783233.USD","00013","09926","BK1588","03329","BK1147","06996","LU1794554557.SGD","BK1191","BK1583","BK1574","LU0417516571.SGD","06978","02096","IE00B5MMRT66.SGD","LU0348784397.USD","BK1587","LU1720050803.USD"],"gpt_icon":0},{"id":"2548927879","title":"HUTCHMED (China) Ltd. Schedules Board Meeting to Approve and Announce 2025 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548927879","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548927879?lang=en_us&edition=fundamental","pubTime":"2025-07-03 16:35","pubTimestamp":1751531716,"startTime":"0","endTime":"0","summary":"HUTCHMED  Ltd. will hold a board meeting on Thursday, August 7, 2025, to approve and announce the interim results for the six months ended June 30, 2025. Following the announcement, the company will conduct an English webcast presentation with a Q&A session at 8:00 pm Hong Kong Time the same day, and a Chinese webcast at 8:30 am on Friday, August 8, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUTCHMED  Ltd. published the original content used to generate this news brief on July 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL2fpYH5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","BK1588","BK1191","BK1587"],"gpt_icon":0},{"id":"2548879683","title":"HUTCHMED to Announce 2025 Half-Year Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548879683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548879683?lang=en_us&edition=fundamental","pubTime":"2025-07-03 16:30","pubTimestamp":1751531400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nTUA8YYV8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1191","BK1587","BK1588"],"gpt_icon":0},{"id":"2548879987","title":"HUTCHMED to Announce 2025 Half-Year Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548879987","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548879987?lang=en_us&edition=fundamental","pubTime":"2025-07-03 16:30","pubTimestamp":1751531400,"startTime":"0","endTime":"0","summary":"HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July  03, 2025  (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/03/3109729/0/en/HUTCHMED-to-Announce-2025-Half-Year-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BST","BK1588","BK1191","00013","BK1587"],"gpt_icon":0},{"id":"2547064370","title":"Hutchmed New Drug Application for Lung Cancer Combination Treatment Approved in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2547064370","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547064370?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:18","pubTimestamp":1751275082,"startTime":"0","endTime":"0","summary":"Hutchmed  said Monday that the China National Medical Products Administration has approved its new drug application for the combination of Orpathys and Tagrisso to treat a certain type of lung cancer.The approval covers locally advanced or metastatic epidermal growth factor receptor mutation-positive non-squamous non-small cell lung cancer with MET amplification after disease progression on EGFR tyrosine kinase inhibitor therapy.The company said the approval triggers an $11 million milestone payment from AstraZeneca , which markets both the drugs in China.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","LU2456880835.USD","LU0109394709.USD","BK1587","LU0889565916.HKD","BK1588","LU1829250122.USD","LU2236285917.USD","BK4531","LU2417539215.USD","BK4568","LU0320765992.SGD","BK4007","00013","BK4585","HCM","LU2462157665.USD","AZN","BK4588"],"gpt_icon":0},{"id":"2547653870","title":"HUTCHMED (China) Ltd - Announces China Approval for Orpathys and Tagrisso Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2547653870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547653870?lang=en_us&edition=fundamental","pubTime":"2025-06-30 16:30","pubTimestamp":1751272200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nTUC2L0Q7L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1587","BK1191","00013"],"gpt_icon":0},{"id":"2547065802","title":"HUTCHMED China Ltd  - China Approval Based on Phase Iii Sachi Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2547065802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547065802?lang=en_us&edition=fundamental","pubTime":"2025-06-30 16:30","pubTimestamp":1751272200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nTUC2L0Q7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1588","BK1587","BK1191"],"gpt_icon":0},{"id":"2541041883","title":"BUZZ-HUTCHMED hits 2-month high on drug application for kidney cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541041883","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541041883?lang=en_us&edition=fundamental","pubTime":"2025-06-05 15:35","pubTimestamp":1749108945,"startTime":"0","endTime":"0","summary":"BUZZ-HUTCHMED hits 2-month high on drug application for kidney cancer treatment ** Shares of biopharmaceutical group HUTCHMED  Ltd 0013.HK jump 9.7% to HK$26, their highest since April 2** Stock on course for third consecutive session of gains** HUTCHMED and nnovent Biologics 1801.HK say in a joint statement that China National Medical Products Administration  has accepted for review the New Drug Application for the combination of fruquintinib and sintilimab for treatment of renal cell carcinoma in kidney cancer** Fruquintinib is co-developed and co-commercialized in China by HUTCHMED and Eli Lilly LLY.N** Sintilimab is co-developed and co-commercialized by nnovent and Eli Lilly** Hong Kong's healthcare index .HSCIH falls 1.6%, Hang Seng Biotech Index .HSHKBIO drops 1.8%** YTD, HUTCHMEd stock up 5.8%   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL2N3S806Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2237443549.SGD","LU0354030438.USD","00013","LU0689472784.USD","LU1868836591.USD","LU2491049909.HKD","SGXZ81514606.USD","BK4533","LU2471134952.CNY","01801","LU2361045086.USD","LU0820561818.USD","BK1588","LU2491050071.SGD","LU0198837287.USD","LU0256863811.USD","LU0943347566.SGD","BK4534","LU1551013425.SGD","LU1917777945.USD","LU0203202063.USD","LU0058720904.USD","SG9999014906.USD","LU0823416689.USD","LU0266013472.USD","LU0323591593.USD","LU0320765992.SGD","LU1868836914.USD","IE00BJT1NW94.SGD","LU2491050154.USD","LU2462157665.USD","LU0466842654.USD","LU2112291526.USD","LU2328871848.SGD","LU2357305700.SGD","LU1127390331.HKD","LU2461242641.AUD","SGXZ57979304.SGD","LU2264538146.SGD","SGXZ31699556.SGD","BK4581","LU1267930730.SGD","LU2471134879.HKD","LU0882574139.USD","LU1868837136.USD","LU0079474960.USD","LU2361044949.HKD","LU1983299246.USD"],"gpt_icon":1},{"id":"2541909742","title":"HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541909742","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541909742?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:50","pubTimestamp":1749081005,"startTime":"0","endTime":"0","summary":"HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment. HUTCHMED  Limited and Innovent Biologics, Inc. have jointly announced the acceptance of their New Drug Application  by the China National Medical Products Administration . The application is for the combination of fruquintinib and sintilimab for the treatment of patients with advanced renal cell carcinoma who have not responded to prior treatment with a tyrosine kinase inhibitor. This NDA is backed by data from the FRUSICA-2 study, which demonstrated the efficacy and safety of the drug combination compared to monotherapy options. The announcement underscores both companies' commitment to advancing cancer therapies and enhancing treatment options for patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL8P2WdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","BK1191","BK1587","01911","BK1588","BK1147"],"gpt_icon":0},{"id":"2541097438","title":"BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With Sintilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2541097438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541097438?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:47","pubTimestamp":1749080867,"startTime":"0","endTime":"0","summary":"BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With SintilimabJune 5 (Reuters) - HUTCHMED (China) Ltd 0013.HK:NDA ACCEPTANCE IN CHINA FOR FRUQUINTINIB COMBINATION WIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU2328871848.SGD","LU1969619763.USD","BK1583","BK1588","LU2488822045.USD","BK1587","BK1191","BK1161","00013","BK1589"],"gpt_icon":0},{"id":"2541979750","title":"HUTCHMED (China) Ltd - Nda Acceptance in China for Fruquintinib Combination With Sintilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2541979750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541979750?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:45","pubTimestamp":1749080738,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1587","00013","BK1588"],"gpt_icon":0},{"id":"1133424631","title":"HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133424631","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133424631?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:09","pubTimestamp":1747966164,"startTime":"0","endTime":"0","summary":"Hong Kong’s pharma stocks rose on Friday.Hengrui Pharma surged 29%; Asymchem rose 7%; CSPC Pharma rose 4%; Hutchmed, Innovent Bio, Laekna rose 3%; CanSinoBIO rose 2%.Hengrui, which is based in eastern China’s Jiangsu province, began operations in 1970 as state-owned Lianyungang Pharmaceutical Factory. It listed in Shanghai in 2000.Over the years, it has shifted focus to developing novel drugs from making generic medicines. It has spent 44 billion yuan  on R&D since 2000, according to its website","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"97c4ce10e0d7371cbbe9d36dff321fe2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","06185","01276","01093","01801","06821","02105"],"gpt_icon":1},{"id":"2529340744","title":"Hutchmed Completes Patient Enrollment in Phase II Gastric Cancer Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2529340744","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529340744?lang=en_us&edition=fundamental","pubTime":"2025-04-22 16:43","pubTimestamp":1745311386,"startTime":"0","endTime":"0","summary":"Hutchmed   said late Monday it completed enrollment in the registration phase of a phase II trial to assess the efficacy, safety and tolerability of savolitinib in gastric cancer patients with MET amplification.A total of 64 patients have been enrolled in the trial.If positive, the company may begin plans to apply for marketing authorization of savolitinib for gastric cancer in China later this year, it said.Savolitinib is being jointly developed by AstraZeneca  and Hutchmed, and commercialized by AstraZeneca.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00013","BK1588","AZN","BK4531","BK1191","BK4585","LU2456880835.USD","LU1829250122.USD","BK4007","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","LU2417539215.USD","LU2236285917.USD","BK4568","BK4588","BK1587","HCM","LU2462157665.USD"],"gpt_icon":0},{"id":"2529331972","title":"- HUTCHMED China Ltd  - HUTCHMED Completes Enrollment of Phase Ii Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529331972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529331972?lang=en_us&edition=fundamental","pubTime":"2025-04-22 14:00","pubTimestamp":1745301615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nTUC60KPSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1587","BK1191","BK1588"],"gpt_icon":0},{"id":"2527950334","title":"Market Chatter: Hutchmed Looking Into Supply Chain Options for Blood Cancer Drug Amid US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527950334","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527950334?lang=en_us&edition=fundamental","pubTime":"2025-04-15 18:40","pubTimestamp":1744713623,"startTime":"0","endTime":"0","summary":"Hutchmed  is weighing its supply chain options for blood cancer drug, tazemetostat, amid the impact of US tariffs against China, the South China Morning Post reported Monday, citing chief executive and scientific officer Su Weiguo.China's medical products administrator in March approved tazemetostat for follicular-lymphoma patients with an EZH2 mutation and who have not responded to treatment or those who have recurrent cancer.Because tazemetostat is currently made in the US, it could be subjected to tariffs should it be imported into China, the report said.Should the impact of tariffs be substantial, Hutchmed may look to manufacture the anti-cancer drug in Europe or China, Su reportedly said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1588","00013","BK1587","BK1191"],"gpt_icon":0},{"id":"2521766513","title":"Hutchmed's Tazemetostat Gets Conditional Approval in China for Follicular Lymphoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2521766513","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521766513?lang=en_us&edition=fundamental","pubTime":"2025-03-24 14:49","pubTimestamp":1742798945,"startTime":"0","endTime":"0","summary":"Hutchmed (China) (HKG:0013) obtained conditional approval from China's National Medical Product Association for Tazemetostat as a treatment for patients with relapsed or refractory follicular lymphoma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1587","00013","BK4585","FL","BK4588","BK1588","BK4094"],"gpt_icon":1},{"id":"2521288283","title":"BRIEF-Hutchmed (China) Gets NMPA Conditional Approval For Tazverik® (Tazemetostat)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288283","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288283?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:00","pubTimestamp":1742558449,"startTime":"0","endTime":"0","summary":"BRIEF-Hutchmed  Gets NMPA Conditional Approval For Tazverik March 21  - HUTCHMED  Ltd 0013.HK:NMPA CONDITIONAL APPROVAL FOR TAZVERIK  FOR TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMAFurther company coverage: 0013.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31AA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","BK1587","BK1191","BK1588"],"gpt_icon":0},{"id":"2521077364","title":"Hutchmed Receives Conditional Approval for Tazverik as Follicular Lymphoma Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2521077364","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521077364?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:28","pubTimestamp":1742556531,"startTime":"0","endTime":"0","summary":"Hutchmed   said Friday that China's National Medical Products Administration granted conditional approval for the new drug application for Tazverik as a treatment for adult patients with relapsed or refractory follicular lymphoma.The company said results of a phase 2 trial supported the conditional approval, with Tazverik demonstrating \"promising efficacy.\" Hutchmed said the ongoing SYMPHONY-1 study is intended to be the confirmatory trial to validate Tazverik's clinical benefits.Hutchmed is in charge of Tazverik's development and commercialization in China, Hong Kong, Macau and Taiwan, while Epizyme is the marketing authorization holder in China, according to the statement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4531","BK1588","BK4007","BK4585","BK1191","BK1587","00013","HCM"],"gpt_icon":0},{"id":"2521403466","title":"HUTCHMED (China) Ltd - Nmpa Conditional Approval for Tazverik® (Tazemetostat) for Treatment of Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403466?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:01","pubTimestamp":1742551278,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31AA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1587","BK1191","00013"],"gpt_icon":0},{"id":"2521034408","title":"HUTCHMED Announces Nmpa Conditional Approval for Tazverik® (Tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2521034408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521034408?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA5F2QXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1587","BK1191","BK1588"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00013\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"00013","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754530200000,"name":null,"time":"","dateTimestamp":1754496000000,"actualEps":null},{"market":"HK","date":"2025-03-19","symbol":"00013","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742313600000,"reportTimeType":"post","actualEps":null},{"date":"2024-07-31","symbol":"00013","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722389400000,"name":null,"time":"Post Market","dateTimestamp":1722355200000,"actualEps":null},{"date":"2024-02-28","symbol":"00013","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709083800000,"name":null,"time":"","dateTimestamp":1709049600000,"actualEps":null},{"date":"2023-07-31","symbol":"00013","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690767000000,"name":null,"time":"","dateTimestamp":1690732800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00013\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00013\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1747238400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00013\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00013","date":"2025-07-15","current":74.091687,"percent":0.995134,"low":-115.327022,"twenty":-64.57142,"median":-32.034774,"eighty":-6.043621,"high":80.718194,"avg":-27.327431,"sd":41.861475,"marketCap":21943763626.33},"quantilePoints":[{"date":"2020-07-17","current":-35.248695,"twenty":-38.235621,"median":-30.73121,"eighty":-26.291308,"marketCap":28977972139.34},{"date":"2020-07-24","current":-34.41247,"twenty":-38.18404,"median":-31.044591,"eighty":-26.70395,"marketCap":28283760815.36},{"date":"2020-07-31","current":-33.674307,"twenty":-38.100039,"median":-31.430081,"eighty":-26.752138,"marketCap":28798873654.83},{"date":"2020-08-07","current":-39.738669,"twenty":-38.18404,"median":-31.647897,"eighty":-26.802194,"marketCap":33985795083.63},{"date":"2020-08-14","current":-38.624972,"twenty":-38.554998,"median":-32.95807,"eighty":-26.878281,"marketCap":33034433418.14},{"date":"2020-08-21","current":-41.184244,"twenty":-39.619393,"median":-33.534702,"eighty":-26.990402,"marketCap":35222733028.49},{"date":"2020-08-28","current":-41.901826,"twenty":-39.844279,"median":-34.098254,"eighty":-27.188355,"marketCap":35836397444.5},{"date":"2020-09-04","current":-42.126616,"twenty":-39.993112,"median":-34.715912,"eighty":-27.705673,"marketCap":36029066379.98},{"date":"2020-09-11","current":-42.427136,"twenty":-40.108093,"median":-35.239073,"eighty":-27.72108,"marketCap":36285152753.14},{"date":"2020-09-18","current":-43.829981,"twenty":-40.813351,"median":-35.366914,"eighty":-27.735248,"marketCap":37483945981.29},{"date":"2020-09-25","current":-41.022467,"twenty":-40.986845,"median":-35.571884,"eighty":-27.793281,"marketCap":35082880575.02},{"date":"2020-09-30","current":-40.612866,"twenty":-40.913412,"median":-35.869501,"eighty":-27.865468,"marketCap":34732539173.21},{"date":"2020-10-09","current":-42.858118,"twenty":-41.04827,"median":-36.105478,"eighty":-27.893752,"marketCap":36652607909.29},{"date":"2020-10-16","current":-40.232946,"twenty":-41.207441,"median":-36.208873,"eighty":-28.057836,"marketCap":34407805902.95},{"date":"2020-10-23","current":-38.382485,"twenty":-41.158034,"median":-36.490673,"eighty":-28.155604,"marketCap":32825094779.95},{"date":"2020-10-30","current":-37.255193,"twenty":-41.074073,"median":-36.624364,"eighty":-28.178399,"marketCap":31880715505.62},{"date":"2020-11-06","current":-41.808936,"twenty":-41.164586,"median":-36.803615,"eighty":-28.189312,"marketCap":35771670803.86},{"date":"2020-11-13","current":-39.268854,"twenty":-41.074073,"median":-36.935473,"eighty":-28.198151,"marketCap":33598119461.44},{"date":"2020-11-20","current":-38.350657,"twenty":-41.01578,"median":-37.059578,"eighty":-28.202601,"marketCap":32807863187.73},{"date":"2020-11-27","current":-40.061625,"twenty":-40.972588,"median":-37.290315,"eighty":-28.263324,"marketCap":34263854227.4},{"date":"2020-12-04","current":-38.192608,"twenty":-40.912067,"median":-37.42678,"eighty":-28.315813,"marketCap":32664775423.76},{"date":"2020-12-11","current":-37.312576,"twenty":-40.881317,"median":-37.480975,"eighty":-28.426548,"marketCap":31913268460.42},{"date":"2020-12-18","current":-37.54654,"twenty":-40.841459,"median":-37.515467,"eighty":-28.513985,"marketCap":32118762883.81},{"date":"2020-12-24","current":-36.443995,"twenty":-40.813677,"median":-37.515467,"eighty":-28.551832,"marketCap":31176729725.48},{"date":"2020-12-31","current":-41.217215,"twenty":-40.815975,"median":-37.542473,"eighty":-28.596048,"marketCap":35264258759.76},{"date":"2021-01-08","current":-46.489494,"twenty":-46.540499,"median":-42.543554,"eighty":-38.429485,"marketCap":39788405946.76},{"date":"2021-01-15","current":-44.782429,"twenty":-46.119623,"median":-45.229655,"eighty":-40.184093,"marketCap":38315589532.96},{"date":"2021-01-22","current":-43.131259,"twenty":-45.805798,"median":-44.05441,"eighty":-41.677355,"marketCap":36897575432.12},{"date":"2021-01-29","current":-40.507012,"twenty":-45.694177,"median":-43.378121,"eighty":-41.677355,"marketCap":34658237647.8},{"date":"2021-02-05","current":-45.584773,"twenty":-45.678217,"median":-43.968485,"eighty":-41.883225,"marketCap":38995330333.28},{"date":"2021-02-11","current":-47.153468,"twenty":-45.923863,"median":-44.352097,"eighty":-42.099019,"marketCap":40340751302.49},{"date":"2021-02-19","current":-44.811155,"twenty":-45.850627,"median":-44.782429,"eighty":-42.283443,"marketCap":38340514399.95},{"date":"2021-02-26","current":-38.841579,"twenty":-45.752989,"median":-44.203254,"eighty":-41.32015,"marketCap":33247719898.72},{"date":"2021-03-05","current":-33.870975,"twenty":-45.706784,"median":-43.624984,"eighty":-39.848011,"marketCap":33065371412.63},{"date":"2021-03-12","current":-32.350855,"twenty":-45.636674,"median":-43.045484,"eighty":-38.967931,"marketCap":31588726843.85},{"date":"2021-03-19","current":-33.249369,"twenty":-45.519663,"median":-42.352317,"eighty":-34.334408,"marketCap":32459260303.03},{"date":"2021-03-26","current":-30.982552,"twenty":-45.254669,"median":-42.127746,"eighty":-33.270905,"marketCap":30262670351.92},{"date":"2021-04-01","current":-32.26063,"twenty":-45.236445,"median":-41.474553,"eighty":-32.902271,"marketCap":31542771226.27},{"date":"2021-04-09","current":-33.137949,"twenty":-45.21463,"median":-40.874511,"eighty":-32.866224,"marketCap":32408776001.33},{"date":"2021-04-16","current":-34.129797,"twenty":-45.176895,"median":-39.924045,"eighty":-32.896113,"marketCap":33342066085.87},{"date":"2021-04-23","current":-34.843079,"twenty":-45.158193,"median":-39.648909,"eighty":-32.910215,"marketCap":33996392320.16},{"date":"2021-04-30","current":-34.438006,"twenty":-44.949106,"median":-38.737994,"eighty":-32.910215,"marketCap":33629567311.94},{"date":"2021-05-07","current":-31.821317,"twenty":-44.793919,"median":-36.188138,"eighty":-32.856988,"marketCap":31073264544.25},{"date":"2021-05-14","current":-30.312709,"twenty":-44.759774,"median":-35.109797,"eighty":-32.442963,"marketCap":29599244477.97},{"date":"2021-05-21","current":-32.458918,"twenty":-44.587641,"median":-34.795304,"eighty":-32.328974,"marketCap":31688898903.52},{"date":"2021-05-28","current":-34.354172,"twenty":-44.233022,"median":-34.67679,"eighty":-32.308223,"marketCap":33523295987.97},{"date":"2021-06-04","current":-35.068157,"twenty":-44.02004,"median":-34.722902,"eighty":-32.328974,"marketCap":34200039176.59},{"date":"2021-06-11","current":-35.414599,"twenty":-43.831085,"median":-34.901165,"eighty":-32.39408,"marketCap":34554826169.67},{"date":"2021-06-18","current":-34.032624,"twenty":-43.526239,"median":-34.747528,"eighty":-32.372468,"marketCap":33217655857.6},{"date":"2021-06-25","current":-35.828259,"twenty":-43.128739,"median":-34.687533,"eighty":-32.321681,"marketCap":41915439893.14},{"date":"2021-07-02","current":-43.838432,"twenty":-43.131259,"median":-34.795304,"eighty":-32.350855,"marketCap":51323800350.72},{"date":"2021-07-09","current":-41.097094,"twenty":-43.11866,"median":-34.946623,"eighty":-32.458918,"marketCap":48120392047.72},{"date":"2021-07-16","current":-44.549309,"twenty":-43.11866,"median":-35.17764,"eighty":-32.504369,"marketCap":52161498140.45},{"date":"2021-07-23","current":-45.310589,"twenty":-43.968485,"median":-35.414599,"eighty":-32.664215,"marketCap":53066586722.65},{"date":"2021-07-30","current":-39.696122,"twenty":-43.968485,"median":-35.710349,"eighty":-32.718751,"marketCap":55052104811.77},{"date":"2021-08-06","current":-40.119386,"twenty":-43.838432,"median":-35.936715,"eighty":-32.772304,"marketCap":55685993250.74},{"date":"2021-08-13","current":-39.097534,"twenty":-43.624984,"median":-36.168385,"eighty":-32.812154,"marketCap":54295491499.18},{"date":"2021-08-20","current":-36.065012,"twenty":-43.131259,"median":-36.652871,"eighty":-32.886877,"marketCap":50128829049.46},{"date":"2021-08-27","current":-35.744125,"twenty":-43.11866,"median":-36.55385,"eighty":-32.893559,"marketCap":49673817384.05},{"date":"2021-09-03","current":-40.719987,"twenty":-42.972307,"median":-36.652871,"eighty":-32.902271,"marketCap":56467462622.34},{"date":"2021-09-10","current":-37.614485,"twenty":-42.965897,"median":-36.860519,"eighty":-32.915511,"marketCap":52205212399.58},{"date":"2021-09-17","current":-36.698865,"twenty":-42.817468,"median":-36.851163,"eighty":-32.915735,"marketCap":50954788056.29},{"date":"2021-09-24","current":-35.293788,"twenty":-42.619127,"median":-36.851163,"eighty":-32.99451,"marketCap":49026569695.65},{"date":"2021-09-30","current":-35.120905,"twenty":-42.553949,"median":-36.698865,"eighty":-33.041991,"marketCap":48786918724.09},{"date":"2021-10-08","current":-32.006355,"twenty":-42.428812,"median":-36.55385,"eighty":-32.898786,"marketCap":44454288673.24},{"date":"2021-10-15","current":-30.941818,"twenty":-42.344074,"median":-36.22121,"eighty":-32.836106,"marketCap":42945143744.04},{"date":"2021-10-22","current":-31.083316,"twenty":-42.330034,"median":-36.065012,"eighty":-32.568307,"marketCap":43112971697.72},{"date":"2021-10-29","current":-28.737101,"twenty":-42.305064,"median":-35.939257,"eighty":-32.328974,"marketCap":39889709839.27},{"date":"2021-11-05","current":-29.069569,"twenty":-42.156472,"median":-35.828259,"eighty":-32.087231,"marketCap":40376051865.9},{"date":"2021-11-12","current":-29.581373,"twenty":-41.977957,"median":-35.758877,"eighty":-32.000321,"marketCap":41129304488.44},{"date":"2021-11-19","current":-29.210209,"twenty":-41.873989,"median":-35.52649,"eighty":-31.797403,"marketCap":40609180641.02},{"date":"2021-11-26","current":-34.003345,"twenty":-41.725093,"median":-35.418736,"eighty":-31.732478,"marketCap":47319747389.9},{"date":"2021-12-03","current":-32.23822,"twenty":-41.515823,"median":-35.293788,"eighty":-31.797403,"marketCap":44836616278.36},{"date":"2021-12-10","current":-32.455639,"twenty":-41.169167,"median":-35.18636,"eighty":-31.732478,"marketCap":45164307712.51},{"date":"2021-12-17","current":-33.631509,"twenty":-41.080874,"median":-35.068157,"eighty":-31.732478,"marketCap":46818195775.34},{"date":"2021-12-24","current":-34.101039,"twenty":-41.005597,"median":-34.923894,"eighty":-31.797403,"marketCap":47456795061.09},{"date":"2021-12-31","current":-34.446938,"twenty":-40.918244,"median":-34.795304,"eighty":-31.841664,"marketCap":47928518291.92},{"date":"2022-01-07","current":-32.437839,"twenty":-34.216934,"median":-33.768287,"eighty":-32.546096,"marketCap":45137280104.46},{"date":"2022-01-14","current":-30.159284,"twenty":-34.182769,"median":-32.528053,"eighty":-31.719401,"marketCap":41896495107.79},{"date":"2022-01-21","current":-28.701706,"twenty":-33.928688,"median":-32.110119,"eighty":-30.184656,"marketCap":39875505431.45},{"date":"2022-01-28","current":-25.003785,"twenty":-33.624079,"median":-30.96176,"eighty":-28.08003,"marketCap":34769543283.8},{"date":"2022-02-04","current":-26.206511,"twenty":-33.52794,"median":-30.605361,"eighty":-26.57407,"marketCap":36424157188.83},{"date":"2022-02-11","current":-25.261882,"twenty":-32.618267,"median":-30.159284,"eighty":-26.206511,"marketCap":35152831390.55},{"date":"2022-02-18","current":-25.371388,"twenty":-32.437839,"median":-29.083035,"eighty":-25.697923,"marketCap":35312817513.19},{"date":"2022-02-25","current":-25.683001,"twenty":-32.420193,"median":-26.763849,"eighty":-25.683001,"marketCap":35785944440.17},{"date":"2022-03-04","current":-18.605078,"twenty":-32.110119,"median":-26.464292,"eighty":-25.530976,"marketCap":28297581052.3},{"date":"2022-03-11","current":-15.051903,"twenty":-32.070016,"median":-26.326525,"eighty":-25.261882,"marketCap":22932572633.44},{"date":"2022-03-18","current":-17.884701,"twenty":-31.193478,"median":-26.166616,"eighty":-21.714134,"marketCap":27233209728.79},{"date":"2022-03-25","current":-16.435173,"twenty":-30.730042,"median":-25.903371,"eighty":-17.884701,"marketCap":25043178568.8},{"date":"2022-04-01","current":-17.213787,"twenty":-30.48068,"median":-25.690905,"eighty":-17.432216,"marketCap":26250069985.91},{"date":"2022-04-08","current":-16.063966,"twenty":-30.257393,"median":-25.643815,"eighty":-17.055219,"marketCap":24511508861.84},{"date":"2022-04-14","current":-15.298862,"twenty":-30.176199,"median":-25.515985,"eighty":-16.890995,"marketCap":23354155045.87},{"date":"2022-04-22","current":-14.712002,"twenty":-30.080898,"median":-25.416472,"eighty":-16.438181,"marketCap":22468433581.99},{"date":"2022-04-29","current":-13.558507,"twenty":-29.763736,"median":-25.004766,"eighty":-15.67506,"marketCap":20708827698.25},{"date":"2022-05-06","current":-9.781934,"twenty":-29.311832,"median":-24.536918,"eighty":-15.316521,"marketCap":14946095060.81},{"date":"2022-05-13","current":-9.355898,"twenty":-28.701706,"median":-18.605078,"eighty":-15.051903,"marketCap":14295669518.62},{"date":"2022-05-20","current":-8.719868,"twenty":-27.147517,"median":-18.156841,"eighty":-13.674415,"marketCap":13321483301.1},{"date":"2022-05-27","current":-8.314191,"twenty":-26.763849,"median":-17.757208,"eighty":-13.413532,"marketCap":12702840396.03},{"date":"2022-06-02","current":-8.658358,"twenty":-26.680207,"median":-17.536296,"eighty":-11.400721,"marketCap":13222054770.59},{"date":"2022-06-10","current":-9.214019,"twenty":-26.591115,"median":-17.134659,"eighty":-9.756609,"marketCap":14077985103.01},{"date":"2022-06-17","current":-9.914833,"twenty":-26.398424,"median":-17.044989,"eighty":-9.414775,"marketCap":15149735584.26},{"date":"2022-06-24","current":-11.463874,"twenty":-26.337619,"median":-16.800427,"eighty":-9.431663,"marketCap":17514907422.39},{"date":"2022-06-30","current":-10.693051,"twenty":-26.329273,"median":-16.438933,"eighty":-9.566068,"marketCap":16333469323.64},{"date":"2022-07-08","current":-13.343207,"twenty":-26.317962,"median":-16.04464,"eighty":-9.731284,"marketCap":20384557250.66},{"date":"2022-07-15","current":-11.176596,"twenty":-26.248808,"median":-15.477934,"eighty":-9.861673,"marketCap":17077603475.67},{"date":"2022-07-22","current":-11.270185,"twenty":-26.158638,"median":-15.298862,"eighty":-9.932971,"marketCap":17217623503.66},{"date":"2022-07-29","current":-11.175537,"twenty":-26.077318,"median":-15.12716,"eighty":-9.984048,"marketCap":17075877541.41},{"date":"2022-08-05","current":-8.775775,"twenty":-25.959775,"median":-14.816492,"eighty":-9.566068,"marketCap":17574625072.99},{"date":"2022-08-12","current":-9.033436,"twenty":-25.816533,"median":-13.616461,"eighty":-9.292049,"marketCap":18064375615.29},{"date":"2022-08-19","current":-8.567373,"twenty":-25.72221,"median":-13.480194,"eighty":-9.144939,"marketCap":17149292220.93},{"date":"2022-08-26","current":-8.387311,"twenty":-25.689502,"median":-13.337024,"eighty":-9.034157,"marketCap":16788221392.11},{"date":"2022-09-02","current":-8.548157,"twenty":-25.683356,"median":-13.200554,"eighty":-8.98009,"marketCap":17117960263.18},{"date":"2022-09-09","current":-9.050042,"twenty":-25.635977,"median":-12.78636,"eighty":-8.905022,"marketCap":18121776670.85},{"date":"2022-09-16","current":-7.943729,"twenty":-25.575167,"median":-12.324077,"eighty":-8.748156,"marketCap":15907654280.04},{"date":"2022-09-23","current":-5.590294,"twenty":-25.518983,"median":-11.743958,"eighty":-8.673581,"marketCap":11195071623.1},{"date":"2022-09-30","current":-6.0166,"twenty":-25.485219,"median":-11.587891,"eighty":-8.586381,"marketCap":12048940501.69},{"date":"2022-10-07","current":-5.591973,"twenty":-25.443523,"median":-11.527599,"eighty":-8.493517,"marketCap":11198562277.42},{"date":"2022-10-14","current":-5.380359,"twenty":-25.349487,"median":-11.463874,"eighty":-8.390524,"marketCap":10774823368.78},{"date":"2022-10-21","current":-5.717908,"twenty":-25.210459,"median":-11.223391,"eighty":-8.363292,"marketCap":11450514084.98},{"date":"2022-10-28","current":-5.527847,"twenty":-25.00457,"median":-11.166052,"eighty":-8.300859,"marketCap":11069565111.71},{"date":"2022-11-04","current":-5.851883,"twenty":-24.910412,"median":-11.069492,"eighty":-8.060636,"marketCap":11719091896.58},{"date":"2022-11-11","current":-6.401199,"twenty":-23.972361,"median":-10.858934,"eighty":-8.011233,"marketCap":12796562986.74},{"date":"2022-11-18","current":-7.274108,"twenty":-21.092323,"median":-10.673386,"eighty":-7.934524,"marketCap":14517459126.03},{"date":"2022-11-25","current":-7.207228,"twenty":-18.572304,"median":-10.157769,"eighty":-7.463009,"marketCap":14371885026.64},{"date":"2022-12-02","current":-9.190517,"twenty":-18.408401,"median":-9.929948,"eighty":-7.665665,"marketCap":18250194105.54},{"date":"2022-12-09","current":-9.61663,"twenty":-18.229044,"median":-9.65531,"eighty":-7.784213,"marketCap":19100477041.28},{"date":"2022-12-16","current":-9.580976,"twenty":-18.006141,"median":-9.63597,"eighty":-7.910568,"marketCap":19026485178.56},{"date":"2022-12-23","current":-9.787361,"twenty":-17.859202,"median":-9.65531,"eighty":-7.934524,"marketCap":19486173353.19},{"date":"2022-12-30","current":-10.536978,"twenty":-17.782707,"median":-9.784648,"eighty":-7.941428,"marketCap":20959995729.67},{"date":"2023-01-06","current":-11.292055,"twenty":-17.736585,"median":-9.867971,"eighty":-7.950701,"marketCap":22494681234.05},{"date":"2023-01-13","current":-12.006871,"twenty":-17.610912,"median":-10.008346,"eighty":-7.963783,"marketCap":23922940068.79},{"date":"2023-01-20","current":-11.709152,"twenty":-17.473848,"median":-10.118738,"eighty":-7.994464,"marketCap":23379819079.96},{"date":"2023-01-27","current":-13.678274,"twenty":-17.432216,"median":-10.177881,"eighty":-8.01117,"marketCap":27320803442.63},{"date":"2023-02-03","current":-13.421402,"twenty":-17.213787,"median":-10.426285,"eighty":-8.011486,"marketCap":26863129451.21},{"date":"2023-02-10","current":-11.253893,"twenty":-17.05553,"median":-10.648788,"eighty":-8.019975,"marketCap":22537144573},{"date":"2023-02-17","current":-11.126783,"twenty":-17.053975,"median":-10.857338,"eighty":-8.035671,"marketCap":22268002032.65},{"date":"2023-02-24","current":-10.526624,"twenty":-17.044989,"median":-10.726474,"eighty":-8.057762,"marketCap":21077513939.38},{"date":"2023-03-03","current":-8.154844,"twenty":-16.916563,"median":-10.643856,"eighty":-8.057762,"marketCap":23097865737.18},{"date":"2023-03-10","current":-6.963075,"twenty":-7.3495,"median":-7.032846,"eighty":-6.75848,"marketCap":19723143000.14},{"date":"2023-03-17","current":-6.865923,"twenty":-61.970531,"median":-35.629537,"eighty":-17.473848,"marketCap":19447482927.55},{"date":"2023-03-24","current":-6.741371,"twenty":-61.810647,"median":-35.43635,"eighty":-16.967933,"marketCap":19094937026.98},{"date":"2023-03-31","current":-6.375327,"twenty":-61.252739,"median":-35.347363,"eighty":-16.28669,"marketCap":18058416376.4},{"date":"2023-04-06","current":-6.683867,"twenty":-61.051241,"median":-35.293788,"eighty":-15.784823,"marketCap":18932274586.01},{"date":"2023-04-14","current":-8.330975,"twenty":-60.256652,"median":-35.239073,"eighty":-15.273506,"marketCap":23597702760.41},{"date":"2023-04-21","current":-7.844979,"twenty":-58.817812,"median":-35.05056,"eighty":-14.753798,"marketCap":22220992691.66},{"date":"2023-04-28","current":-7.371003,"twenty":-58.196617,"median":-34.901165,"eighty":-13.506657,"marketCap":20878585601.39},{"date":"2023-05-05","current":-7.738249,"twenty":-57.924962,"median":-34.698276,"eighty":-13.335787,"marketCap":21913541487.16},{"date":"2023-05-12","current":-6.663943,"twenty":-56.833588,"median":-34.455845,"eighty":-12.953628,"marketCap":18842198331.81},{"date":"2023-05-19","current":-5.998961,"twenty":-55.969951,"median":-34.41247,"eighty":-12.439757,"marketCap":16945371089.92},{"date":"2023-05-25","current":-5.942503,"twenty":-55.282066,"median":-34.29379,"eighty":-12.225939,"marketCap":16798971651.82},{"date":"2023-06-02","current":-5.896649,"twenty":-54.016998,"median":-34.217465,"eighty":-11.933092,"marketCap":16663068843.98},{"date":"2023-06-09","current":-5.61732,"twenty":-51.214539,"median":-34.101039,"eighty":-11.666701,"marketCap":15883210799.3},{"date":"2023-06-16","current":-6.556151,"twenty":-49.105276,"median":-34.003345,"eighty":-11.555566,"marketCap":18505315840.32},{"date":"2023-06-23","current":-5.188019,"twenty":-48.556583,"median":-33.893107,"eighty":-11.468392,"marketCap":14659329250.62},{"date":"2023-06-30","current":-5.593173,"twenty":-48.07849,"median":-33.659861,"eighty":-11.27436,"marketCap":15818891198.39},{"date":"2023-07-07","current":-5.74663,"twenty":-47.632394,"median":-33.542687,"eighty":-11.176172,"marketCap":16220083293.9},{"date":"2023-07-14","current":-6.162744,"twenty":-47.405428,"median":-33.247944,"eighty":-11.098403,"marketCap":17394445526.77},{"date":"2023-07-21","current":-6.029127,"twenty":-47.160973,"median":-33.142575,"eighty":-10.97509,"marketCap":16998620863},{"date":"2023-07-28","current":-6.932729,"twenty":-46.570339,"median":-32.990093,"eighty":-10.818361,"marketCap":19517985603.8},{"date":"2023-08-04","current":-93.761454,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":21537453624.06},{"date":"2023-08-11","current":-81.599272,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18771592602.56},{"date":"2023-08-18","current":-77.394943,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":17836124479.76},{"date":"2023-08-25","current":-81.144511,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18729505678.13},{"date":"2023-09-01","current":-88.78076,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":20494743445.14},{"date":"2023-09-08","current":-82.097217,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":18936651957.48},{"date":"2023-09-15","current":-90.981817,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":20957716756.3},{"date":"2023-09-22","current":-92.393328,"twenty":-46.5265,"median":-32.963473,"eighty":-10.733158,"marketCap":21259996622.03},{"date":"2023-09-29","current":-98.461442,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":22686128273.82},{"date":"2023-10-06","current":-96.214145,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":22171083111.85},{"date":"2023-10-13","current":-103.485392,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":23822424537.65},{"date":"2023-10-20","current":-97.284175,"twenty":-46.617006,"median":-32.990093,"eighty":-10.759896,"marketCap":22394985002.25},{"date":"2023-10-27","current":-106.751795,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24568605371.22},{"date":"2023-11-03","current":-115.212824,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":26525615085.48},{"date":"2023-11-10","current":-109.532922,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":25174318402.02},{"date":"2023-11-17","current":-106.805345,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24505823305.05},{"date":"2023-11-24","current":-109.693138,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":25153240209.05},{"date":"2023-12-01","current":-106.604844,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24511417094.04},{"date":"2023-12-08","current":-107.070217,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24605471525.28},{"date":"2023-12-15","current":-113.448896,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":26053877959.74},{"date":"2023-12-22","current":-103.305924,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":23753967779.21},{"date":"2023-12-29","current":-104.554671,"twenty":-46.554784,"median":-32.968877,"eighty":-10.746527,"marketCap":24031688424.97},{"date":"2024-01-05","current":-97.538826,"twenty":-46.632577,"median":-32.968877,"eighty":-10.746527,"marketCap":22413571331.52},{"date":"2024-01-12","current":-94.201699,"twenty":-46.770261,"median":-32.968877,"eighty":-10.746527,"marketCap":21673419911.77},{"date":"2024-01-19","current":-81.584808,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":18770785863.8},{"date":"2024-01-26","current":-75.451844,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":17345101973.87},{"date":"2024-02-02","current":-70.765941,"twenty":-47.074928,"median":-32.968877,"eighty":-10.746527,"marketCap":16282696381.87},{"date":"2024-02-09","current":-81.347748,"twenty":-48.716981,"median":-33.012756,"eighty":-10.798873,"marketCap":18717344761},{"date":"2024-02-16","current":-84.181649,"twenty":-47.153468,"median":-32.990093,"eighty":-10.759896,"marketCap":19373856860.76},{"date":"2024-02-23","current":-90.792994,"twenty":-47.153468,"median":-32.990093,"eighty":-10.759896,"marketCap":20902012964.26},{"date":"2024-03-01","current":25.786241,"twenty":-46.679291,"median":-32.915735,"eighty":-10.645829,"marketCap":20346139014.44},{"date":"2024-03-08","current":25.582581,"twenty":-45.940803,"median":-32.886877,"eighty":-10.481626,"marketCap":20163555295.01},{"date":"2024-03-15","current":30.565906,"twenty":-45.529936,"median":-32.817455,"eighty":-10.09532,"marketCap":24095754961.33},{"date":"2024-03-22","current":28.107757,"twenty":-45.160354,"median":-32.772304,"eighty":-9.839853,"marketCap":22154601659.66},{"date":"2024-03-28","current":28.600698,"twenty":-44.720712,"median":-32.618267,"eighty":-9.624366,"marketCap":22551295932.84},{"date":"2024-04-05","current":27.994802,"twenty":-44.347448,"median":-32.47029,"eighty":-9.452048,"marketCap":22087067767.8},{"date":"2024-04-12","current":30.73697,"twenty":-43.943873,"median":-32.437839,"eighty":-9.318497,"marketCap":24275060175.65},{"date":"2024-04-19","current":28.50518,"twenty":-43.568026,"median":-32.383262,"eighty":-9.184888,"marketCap":22496664763.16},{"date":"2024-04-26","current":30.691652,"twenty":-43.220175,"median":-32.350855,"eighty":-9.070875,"marketCap":24213782936.8},{"date":"2024-05-03","current":32.810779,"twenty":-43.064091,"median":-32.26063,"eighty":-9.029833,"marketCap":25846323266.76},{"date":"2024-05-10","current":37.311124,"twenty":-42.923343,"median":-32.110119,"eighty":-8.913389,"marketCap":29386719562.77},{"date":"2024-05-17","current":34.774349,"twenty":-42.757541,"median":-32.039099,"eighty":-8.809555,"marketCap":27344355739.56},{"date":"2024-05-24","current":31.870114,"twenty":-42.527033,"median":-31.996298,"eighty":-8.709144,"marketCap":25081686249.94},{"date":"2024-05-31","current":31.840964,"twenty":-42.416722,"median":-31.741294,"eighty":-8.632994,"marketCap":25083902865.28},{"date":"2024-06-07","current":30.649626,"twenty":-42.305053,"median":-31.616715,"eighty":-8.516477,"marketCap":24125428073.62},{"date":"2024-06-14","current":31.662211,"twenty":-42.098116,"median":-31.539189,"eighty":-8.407096,"marketCap":24922661857.41},{"date":"2024-06-21","current":30.278072,"twenty":-41.844066,"median":-31.363349,"eighty":-8.36679,"marketCap":23813100405.81},{"date":"2024-06-28","current":29.565199,"twenty":-41.728492,"median":-31.269961,"eighty":-8.329156,"marketCap":23268082119.63},{"date":"2024-07-05","current":31.469656,"twenty":-41.393066,"median":-31.203757,"eighty":-8.265452,"marketCap":24767319836.39},{"date":"2024-07-12","current":32.497273,"twenty":-41.140604,"median":-31.157735,"eighty":-8.113279,"marketCap":25570313091.93},{"date":"2024-07-19","current":32.524385,"twenty":-40.943248,"median":-31.083316,"eighty":-8.013184,"marketCap":25598824089.02},{"date":"2024-07-26","current":31.859649,"twenty":-40.85626,"median":-31.054703,"eighty":-7.947767,"marketCap":25066868429.98},{"date":"2024-08-02","current":-73.252444,"twenty":-40.85626,"median":-30.982552,"eighty":-7.932272,"marketCap":24027736404.41},{"date":"2024-08-09","current":-80.817949,"twenty":-40.943248,"median":-31.054703,"eighty":-7.932272,"marketCap":26435442267.26},{"date":"2024-08-16","current":-75.419733,"twenty":-41.140604,"median":-31.070357,"eighty":-7.932272,"marketCap":24678935821.12},{"date":"2024-08-23","current":-70.090937,"twenty":-41.393066,"median":-31.106867,"eighty":-7.932272,"marketCap":22937152798.66},{"date":"2024-08-30","current":-70.200291,"twenty":-41.753019,"median":-31.106867,"eighty":-7.932272,"marketCap":22976002955.29},{"date":"2024-09-06","current":-70.181618,"twenty":-41.891269,"median":-31.106867,"eighty":-7.932272,"marketCap":22962498278.15},{"date":"2024-09-13","current":-69.744859,"twenty":-42.126905,"median":-31.106867,"eighty":-7.932272,"marketCap":22840730551.22},{"date":"2024-09-20","current":-71.615538,"twenty":-42.327522,"median":-31.095092,"eighty":-7.932223,"marketCap":23428261601.8},{"date":"2024-09-27","current":-77.826204,"twenty":-42.433529,"median":-31.139284,"eighty":-7.932223,"marketCap":25408013958.13},{"date":"2024-10-04","current":-82.757332,"twenty":-42.534448,"median":-31.204035,"eighty":-7.932223,"marketCap":26974955119.6},{"date":"2024-10-10","current":-79.704216,"twenty":-42.711375,"median":-31.339747,"eighty":-7.932272,"marketCap":25991425637.15},{"date":"2024-10-18","current":-82.642206,"twenty":-42.92401,"median":-31.585504,"eighty":-7.932223,"marketCap":26964969038.24},{"date":"2024-10-25","current":-85.256412,"twenty":-43.079868,"median":-31.801389,"eighty":-7.932223,"marketCap":27805638314.63},{"date":"2024-11-01","current":-75.478959,"twenty":-43.248131,"median":-32.012456,"eighty":-7.932223,"marketCap":24628211107.26},{"date":"2024-11-08","current":-72.126697,"twenty":-43.829981,"median":-32.06209,"eighty":-7.932223,"marketCap":23539176621.59},{"date":"2024-11-15","current":-68.34495,"twenty":-44.05441,"median":-32.06209,"eighty":-7.932223,"marketCap":22322467758.14},{"date":"2024-11-22","current":-71.747651,"twenty":-44.586692,"median":-32.06209,"eighty":-7.932223,"marketCap":23437513999.56},{"date":"2024-11-29","current":-69.444249,"twenty":-45.156033,"median":-32.06209,"eighty":-7.932223,"marketCap":22687198483.51},{"date":"2024-12-06","current":-72.472893,"twenty":-45.310589,"median":-32.06209,"eighty":-7.932223,"marketCap":23670440899.03},{"date":"2024-12-13","current":-64.122147,"twenty":-45.873042,"median":-32.06209,"eighty":-7.932223,"marketCap":20927655990.31},{"date":"2024-12-20","current":-60.618869,"twenty":-46.617006,"median":-32.06209,"eighty":-7.932223,"marketCap":19772963718.23},{"date":"2024-12-27","current":-59.140915,"twenty":-47.153468,"median":-32.06209,"eighty":-7.932223,"marketCap":19280402620.65},{"date":"2025-01-03","current":-61.983512,"twenty":-59.140915,"median":-32.06209,"eighty":-7.932223,"marketCap":20230498655.69},{"date":"2025-01-10","current":-62.344458,"twenty":-61.433665,"median":-32.06209,"eighty":-7.932223,"marketCap":20362016758.64},{"date":"2025-01-17","current":-58.299182,"twenty":-61.674651,"median":-32.06209,"eighty":-7.932223,"marketCap":19056175109.75},{"date":"2025-01-24","current":-55.029289,"twenty":-61.674651,"median":-32.06209,"eighty":-7.932223,"marketCap":17990698549.08},{"date":"2025-01-28","current":-55.208549,"twenty":-61.626454,"median":-32.070016,"eighty":-7.932272,"marketCap":18051528064.93},{"date":"2025-02-07","current":-53.467713,"twenty":-61.736423,"median":-32.054164,"eighty":-7.928331,"marketCap":17473800278.65},{"date":"2025-02-14","current":-55.098914,"twenty":-61.736423,"median":-32.054164,"eighty":-7.928331,"marketCap":18014663367.55},{"date":"2025-02-21","current":-65.870772,"twenty":-62.054363,"median":-32.054164,"eighty":-7.928331,"marketCap":21496146081.23},{"date":"2025-02-28","current":-68.37646,"twenty":-63.154322,"median":-32.054164,"eighty":-7.928331,"marketCap":22314794720.11},{"date":"2025-03-07","current":-68.073966,"twenty":-64.442069,"median":-32.090068,"eighty":-7.92444,"marketCap":22204161239.42},{"date":"2025-03-14","current":-64.060444,"twenty":-64.442069,"median":-32.282371,"eighty":-7.92444,"marketCap":20896010785.32},{"date":"2025-03-21","current":66.690257,"twenty":-64.57142,"median":-32.359711,"eighty":-7.893063,"marketCap":19556601497.91},{"date":"2025-03-28","current":69.598373,"twenty":-64.57142,"median":-32.359711,"eighty":-7.730879,"marketCap":20419240129.11},{"date":"2025-04-03","current":69.339758,"twenty":-64.57142,"median":-32.359711,"eighty":-7.359957,"marketCap":20359402498.56},{"date":"2025-04-11","current":62.287088,"twenty":-64.57142,"median":-32.359711,"eighty":-7.206069,"marketCap":18236887121.65},{"date":"2025-04-17","current":63.677927,"twenty":-64.517393,"median":-32.350855,"eighty":-7.140497,"marketCap":18650762717},{"date":"2025-04-25","current":68.867703,"twenty":-64.625448,"median":-32.368566,"eighty":-7.03606,"marketCap":20159738053.44},{"date":"2025-05-02","current":70.00808,"twenty":-64.57142,"median":-32.359711,"eighty":-6.966686,"marketCap":20488094665.71},{"date":"2025-05-09","current":68.704213,"twenty":-64.625448,"median":-32.368566,"eighty":-6.932792,"marketCap":20149647112.01},{"date":"2025-05-16","current":61.687385,"twenty":-64.625448,"median":-32.368566,"eighty":-6.786538,"marketCap":18167966631.68},{"date":"2025-05-23","current":63.281782,"twenty":-64.625448,"median":-32.368566,"eighty":-6.729467,"marketCap":18687586410.77},{"date":"2025-05-30","current":63.269782,"twenty":-64.625448,"median":-32.368566,"eighty":-6.664543,"marketCap":18714358918.44},{"date":"2025-06-06","current":69.305193,"twenty":-64.625448,"median":-32.368566,"eighty":-6.561537,"marketCap":20515529753.86},{"date":"2025-06-13","current":77.57647,"twenty":-64.625448,"median":-32.368566,"eighty":-6.458593,"marketCap":22974331108.91},{"date":"2025-06-20","current":66.613989,"twenty":-64.625448,"median":-32.368566,"eighty":-6.38184,"marketCap":19728914894.06},{"date":"2025-06-27","current":68.13786,"twenty":-64.57142,"median":-32.359711,"eighty":-6.322569,"marketCap":20180159014.54},{"date":"2025-07-04","current":70.900488,"twenty":-64.57142,"median":-32.249425,"eighty":-6.168488,"marketCap":20998758486.41},{"date":"2025-07-11","current":72.572229,"twenty":-64.57142,"median":-32.06209,"eighty":-6.069288,"marketCap":21493799797.37},{"date":"2025-07-15","current":74.091687,"twenty":-64.57142,"median":-32.034774,"eighty":-6.043621,"marketCap":21943763626.33}],"updateTime":1752669578083}}}